Tizanidine Hydrochloride Capsule
Product Images NDC 71335-9743

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 71335-9743). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine Structure (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 01)

Chemical structure diagram of tizanidine hydrochloride, detailing the molecular framework including chlorine, nitrogen, sulfur atoms, and hydrogen chloride component.*

FDA Label Image

Figure 1 (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 02)

A pharmacokinetic graph showing plasma tizanidine concentrations (ng/mL) over 24 hours after dosing. It compares four conditions: 2x4 mg tizanidine tablets with food, 2x4 mg tablets without food, 2x4 mg capsules with food, and 2x4 mg capsules without food, illustrating differences in absorption and concentration-time profiles for each scenario.*

FDA Label Image

Figure 2 (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 03)

A line graph depicting the improvement in Ashworth Score over time (hours post-dose) for 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis shows the change in Ashworth Score, and the horizontal axis indicates hours post-dose from 0 to 6. Data points include error bars representing variability.*

FDA Label Image

Figure 3 (49d0fb0e 9403 4e99 Bf59 01b9a45a7dde 04)

A chart showing improvement in Ashworth Score over three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). It compares data for tizanidine (mean dose 28.8 mg) and placebo, with tizanidine showing improvement (lower scores) at each point and placebo showing little to no improvement.*

FDA Label Image

Label (Lbl713359743)

Label for Tizanidine Hydrochloride 6 mg capsules, oral use, containing 30 capsules. Repackaged by Bryant Ranch Prepack, Inc. in Burbank, CA, and manufactured by Ingenuus Pharmaceuticals NJ, LLC. The label includes storage instructions, a warning about drowsiness, and a note to keep the medication out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.